Collegium Pharmaceutical, Inc (COLL) stock
COLLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3048% below fair value
$25.55+0.12 (+0.47%)
Close on Nov 17, 2026Market cap $831.80MP/E 20.6Yield –
Collegium Pharmaceutical pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Collegium Pharmaceutical's pe ratio was 20.0× on Nov 11, 2026, against 29.0× a year earlier. Over the last 5 years it ranged from 6.7× to 219.7×, with a median of 19.5×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 20.0× | −8.8 |
| 2025 | Dec 31, 2025 | 28.8× | +16.4 |
| 2024 | Dec 31, 2024 | 12.3× | −192.9 |
| 2023 | Dec 29, 2023 | 205.2× | +185.9 |
| 2022 | Jul 29, 2022 | 19.3× | +12.2 |
| 2021 | Dec 31, 2021 | 7.1× | −33.7 |
| 2020 | Dec 31, 2020 | 40.9× | – |
See a number that looks wrong?